Inoherb in China: how a Chinese herbal skin care pioneer lost ground in the Douyin era

Updated on July 7, 2026

Inoherb helped to build Chinese mass skin care in the 2000s, then fell behind when beauty moved to Douyin. Its story is a useful check for anyone who assesses a Chinese brand.

By Daxue Consulting

In early 2025, more than 60% of Inoherb’s sales still came from supermarkets, and on Douyin its marketing was behind competitors like Proya (珀莱雅) and Chando (自然堂) (C2CC via Jiemian (界面新闻), March 2025). Its founder, Feng Shuai (封帅), called 2014 to 2016 the “three missed years”.

Inoherb (相宜本草) was founded in Shanghai in 2000 by Feng Shuai, who comes from a family of traditional Chinese medicine doctors. It sold herbal skin care to middle-income women and students in Watsons and in supermarkets, and it was one of the first to use free samples and online reviews. Since then, it gave up three plans to go public, and it changed CEO twice in less than a year. The company is not listed and does not publish its sales. In this article, we will see what went wrong for Inoherb in China and what it means for beauty brands and investors.

Daxue Overview
Origin: founded in 2000 in Shanghai by Feng Shuai; one of the first Chinese herbal skin care brands.
Channels: more than 60% of sales in supermarkets (early 2025); weak on Douyin.
IPO: plans in 2012, withdrawn in 2014; restarted in 2020; CICC tutoring ended in October 2024.
Management: two CEO departures in 2024-2025; founder back in charge.
Disclosure: private company; sales not published.

Inoherb in China: key facts

Exhibit 1: A pioneer held back by channels, governance and trust

Indicator Fact Period Source
Share of sales in supermarkets More than 60% March 2025 C2CC via Jiemian
IPO attempts Filed 2012, withdrawn 2014; restarted 2020; CICC tutoring from November 2022 ended October 2024 2012-2024 Jiemian, March 2025
Amount sought in first IPO About RMB 700 million 2012 Same
CEO changes Yu Wei (俞巍) left in 2024; Zhang Ge (张舸) left after about seven months 2024-2025 Same
Senior management changes before 2020 At least nine Before 2020 Same
Founder’s assessment “Three missed years” 2014-2016 C2CC via Jiemian

Sources: as listed in each row; table designed by Daxue Consulting. Inoherb does not publish its sales.

Four reasons Inoherb fell behind

The channel trap. Inoherb grew in supermarkets and drugstores, which were the main beauty channels of the 2000s. When Chinese beauty moved to Tmall, and then after 2018 to Douyin livestreams, the brand was slow to follow. In March 2025, supermarkets still made more than 60% of its sales (C2CC via Jiemian). For an investor, this is not only about growth. Sales in supermarkets depend on the retailer’s terms and give the brand very little data on its own consumers, so moving to its own online channels is slower and costs more.

The missed years. The “three missed years” of the founder, 2014 to 2016, are exactly the years when Chinese brands born online started to grow big.

The IPO saga. Inoherb filed to list in 2012, to raise about RMB 700 million for marketing and channels, and withdrew in 2014, because of strategic adjustments and weak results in supermarkets. It started again in 2020 and signed with CICC in November 2022, but the tutoring stopped in October 2024 (Jiemian).

Leadership changes. Yu Wei, CEO since 2020, left in 2024. The next CEO, Zhang Ge, proposed a digital transformation and launched the premium line 相宜本草·唐, sold at Sephora, but he left after about seven months (Jiemian).

Choosing Sephora for the premium line is also a risk. Sephora itself has lost money in China for several years and its ownership is changing (see Sephora in China). So the retailer that should lift the image of the brand is looking for a new model too.

In 2024, an online controversy about one of its herbal ingredients, 犁头尖, also hurt consumer trust, and refund rates went up sharply at its Tmall flagship store (C2CC via Jiemian).

Other Chinese herbal and efficacy brands took different paths

Exhibit 2: Inoherb against other Chinese beauty brands

Inoherb (相宜本草) Herborist (佰草集) Proya (珀莱雅)
Founded 2000 1998 2003
Owner Private, founder-led Shanghai Jahwa (listed) Listed group
Story Chinese herbs, affordable Chinese herbal medicine, premium Efficacy, ingredients
Main channel Supermarkets (60%+) Douyin self-livestreams, counters Douyin, Tmall
Recent signal CEO changes, IPO stopped Douyin livestream sales +249.9% (2025) Leader in skin care rankings

Sources: Jiemian, National Business Daily; table designed by Daxue Consulting.

Herborist shows that an older herbal brand can recover with Douyin (see Herborist in China), and Proya shows how efficacy claims and speed online built a leader (see the C-beauty brands report). Chinese brands owned by foreign groups have similar questions, like Yuesai in China.

An early online lead did not carry over to Douyin

In the early 2010s, people praised Inoherb for its free samples, online ads and user reviews. But this lead did not become strength on today’s platforms, which reward brands that publish every day, run their own livestreams, work with creators and launch hero products fast.

How Inoherb has changed over the past decade

Exhibit 3: From fast-growing pioneer to a brand in search of a turnaround

Early 2010s Today
Position Fast-growing Chinese herbal brand Behind Proya, Chando and other Chinese brands
Channels Watsons, supermarkets, early online Still over 60% supermarkets; weak on Douyin
Marketing Free samples, reviews, search visibility Behind rivals on Douyin and Xiaohongshu
IPO Preparing a listing Three abandoned plans
Management Founder-led growth CEO changes, founder back
Products Herbal skin care for students and young women Rhodiola (红景天) core range, premium 相宜本草·唐 line at Sephora

Daxue Take: implications for beauty brands and investors

In short, Inoherb is the other side of the C-beauty success story. It had a good story (Chinese herbs), an accessible price and early digital instincts. What it did not have was speed to change channels and stable management.

  1. For brands built on one channel, the channel that built the brand can become the reason why it falls behind. Checking regularly the channel mix against where consumers buy today limits this risk.
  2. For brands with an early digital lead, being first online in 2010 did not mean success on Douyin. Each time the platforms change, a brand needs new capabilities.
  3. For investors and acquirers assessing Chinese brands, heritage and awareness matter less than channel mix, digital capabilities and management continuity.
  4. For “natural” and herbal brands, one controversy about one ingredient can damage years of brand building. Being transparent on ingredients and answering fast in a crisis are part of the positioning.
  5. For international competitors, the threat comes from the Chinese brands that master current platforms, not from every Chinese brand.

What to watch next

  • Inoherb’s management team and any new listing plan.
  • Its share of sales on Douyin and Tmall.
  • Performance of the premium 相宜本草·唐 line.
  • Consolidation among first-generation Chinese beauty brands.

FAQ about Inoherb

What is Inoherb? Inoherb (相宜本草) is a Chinese herbal skin care brand founded in Shanghai in 2000 by Feng Shuai.

What happened to Inoherb’s IPO plans? Inoherb is not listed. It filed to list in 2012, withdrew in 2014, restarted its plans in 2020, and its IPO tutoring with CICC ended in October 2024.

Where is Inoherb sold? Mainly in supermarkets, which made more than 60% of its sales as of early 2025, as well as at Watsons and on Tmall. Its premium line 相宜本草·唐 is sold at Sephora.

Who are Inoherb’s competitors? Chinese brands such as Proya, Chando and Herborist, and international mass skin care brands.

About Daxue Consulting

Daxue Consulting is a market research and strategy consulting firm focused on China. For beauty brands and investors, Daxue Consulting assesses Chinese brands before a partnership or acquisition, benchmarks channel mix and digital performance, and measures brand image and trust through surveys and social listening. Learn more about our business strategy and consumer research services, or contact our team.

Author: Daxue Consulting

Related articles

Search